Michele Ardolino

Ottawa, ON K1H8L6, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Natural Killer Cell-Derived Extracellular Vesicles Exhibit Cytotoxicity Against Bulk Tumor Cells and Cancer Stem Cells in Triple-Negative Breast Cancer.

Natural Killer Cell-Derived Extracellular Vesicles Exhibit Cytotoxicity Against Bulk Tumor Cells and Cancer Stem Cells in Triple-Negative Breast Cancer.

Journal: Nanomaterials (Basel, Switzerland)

Published: March 16, 2026

Multimeric Branched and Hyperbranched Peptide Ligands of the Natural Cytotoxicity Receptor NKp30 on Natural Killer Cells.

Multimeric Branched and Hyperbranched Peptide Ligands of the Natural Cytotoxicity Receptor NKp30 on Natural Killer Cells.

Journal: Bioconjugate chemistry

Published: January 19, 2026

Preventing surgery-induced natural killer cell suppression and metastases by inhibiting PI3K-gamma signaling in myeloid-derived suppressor cells.

Preventing surgery-induced natural killer cell suppression and metastases by inhibiting PI3K-gamma signaling in myeloid-derived suppressor cells.

Journal: Journal for immunotherapy of cancer

Published: January 16, 2026

Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity.

Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity.

Journal: Molecular therapy. Oncology

Published: December 16, 2025

Feeling exhausted, no longer - macrophages keep type 2 innate lymphoid cells energized.

Feeling exhausted, no longer - macrophages keep type 2 innate lymphoid cells energized.

Journal: Cellular & molecular immunology

Published: September 30, 2025

ILC2s in cancer: good, bad, or stay tuned?

ILC2s in cancer: good, bad, or stay tuned?

Journal: Trends in molecular medicine

Published: April 01, 2025

CD8 T Cell Hyperfunction and Reduced Tumour Control in Murine Models of Advanced Liver Disease.

CD8 T Cell Hyperfunction and Reduced Tumour Control in Murine Models of Advanced Liver Disease.

Journal: European journal of immunology

Published: January 24, 2025

LAG3 Marks Activated but Hyporesponsive NK Cells.

LAG3 Marks Activated but Hyporesponsive NK Cells.

Journal: European journal of immunology

Published: January 15, 2025

Efficacy of chimeric antigen receptor engineered natural killer cells in the treatment of hematologic malignancies: a systematic review and meta-analysis of preclinical studies.

Efficacy of chimeric antigen receptor engineered natural killer cells in the treatment of hematologic malignancies: a systematic review and meta-analysis of preclinical studies.

Journal: Cytotherapy

Published: September 05, 2024

Evaluation of resazurin phenoxazine dye as a highly sensitive cell viability potency assay for natural killer cell-derived extracellular vesicle-based cancer biotherapeutics.

Evaluation of resazurin phenoxazine dye as a highly sensitive cell viability potency assay for natural killer cell-derived extracellular vesicle-based cancer biotherapeutics.

Journal: Journal of extracellular biology

Published: April 13, 2024

Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model.

Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model.

Journal: Frontiers in immunology

Published: January 05, 2024

Sox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses.

Sox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses.

Journal: Cells

Published: November 28, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026